Baxter International Inc. (LON:0QK8)
19.42
-2.86 (-12.82%)
Feb 12, 2026, 4:59 PM GMT
Baxter International Revenue
In the year 2025, Baxter International had annual revenue of $11.24B USD with 5.72% growth. Baxter International had revenue of $2.97B in the quarter ending December 31, 2025, with 8.03% growth.
Revenue
$11.24B
Revenue Growth
+5.72%
P/S Ratio
1.00
Revenue / Employee
$295.89K
Employees
38,000
Market Cap
8.39B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.24B | 608.00M | 5.72% |
| Dec 31, 2024 | 10.64B | 276.00M | 2.66% |
| Dec 31, 2023 | 10.36B | 303.00M | 3.01% |
| Dec 31, 2022 | 10.06B | -2.09B | -17.20% |
| Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
| Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
| Dec 31, 2019 | 11.36B | 263.00M | 2.37% |
| Dec 31, 2018 | 11.10B | 515.00M | 4.87% |
| Dec 31, 2017 | 10.58B | 421.00M | 4.14% |
| Dec 31, 2016 | 10.16B | 195.00M | 1.96% |
| Dec 31, 2015 | 9.97B | -751.00M | -7.01% |
| Dec 31, 2014 | 10.72B | 1.31B | 13.87% |
| Dec 31, 2013 | 9.41B | -4.52B | -32.46% |
| Dec 31, 2012 | 13.94B | 43.00M | 0.31% |
| Dec 31, 2011 | 13.89B | 1.05B | 8.18% |
| Dec 31, 2010 | 12.84B | 281.00M | 2.24% |
| Dec 31, 2009 | 12.56B | 214.00M | 1.73% |
| Dec 31, 2008 | 12.35B | 1.09B | 9.63% |
| Dec 31, 2007 | 11.26B | 885.00M | 8.53% |
| Dec 31, 2006 | 10.38B | 529.00M | 5.37% |
| Dec 31, 2005 | 9.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Baxter International News
- 3 days ago - Is Baxter International Inc (BAX) Set to Underperform? Analyzing the Factors Limiting Growth - GuruFocus
- 6 days ago - Is Baxter International an Underrated Healthcare Investment Play? - The Motley Fool
- 6 days ago - BAX Crosses Above Average Analyst Target - Nasdaq
- 8 days ago - TD Waterhouse Canada Inc. Sells 800 Shares of Baxter International Inc (BAX) - GuruFocus
- 8 days ago - Zurcher Kantonalbank (Zurich Cantonalbank) Sells 392,625 Shares of Baxter International Inc (BAX) - GuruFocus
- 10 days ago - Goldman Sachs Innovate Equity ETF Buys 3,215 Shares of Baxter International Inc (BAX) - GuruFocus
- 11 days ago - Krilogy Financial LLC Buys 11,808 Shares of Baxter International Inc (BAX) - GuruFocus
- 12 days ago - Bayforest Capital Ltd Buys 227 Shares of Baxter International Inc (BAX) - GuruFocus